lobbying_activities: 1162316

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1162316	e9f77976-2fa2-4414-8a64-3a1b27304d7b	Q3	C2 GROUP, LLC	66693	PERRIGO INC	2011	third_quarter	PHA	OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2011-10-19T19:00:06.377000-04:00